The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Enabled more than $66 million to be invested in blood cancer research since 2010.
71 research projects funded enabling over 101 research positions.
Over 6,500 subsidised genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled thousands of patients to participate in over 120 clinical trials.
Latest News

Blood Cancer Patients Join a Global Clinical Trial at Epworth
A global Phase 1 clinical trial is actively recruiting new patients to further investigate the potential benefits of this innovative treatment which uses healthy donor cells to recognise and attack blood cancer cells.
Read more
Celebrating National Volunteer Week 2025
Snowdome Foundation is incredibly fortunate to have the support of a Board of Directors and various committees that are made up entirely of volunteers.
Read more
Eltranatamab to be made available for Australian myeloma patients
We are delighted to share that eltranatamab, an immunotherapy drug, specifically known as a bispecific antibody will be made available later in 2025 for Australian myeloma patients.
Read more